相关实验视频

Updated: Jun 6, 2025

Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections

Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections

Published on: November 8, 2024

外体mRNA签名作为预测性生物标志物,用于阿尔茨海默病发病风险和发病年龄

Daniel A Bolívar¹, María I Mosquera-Heredia², Oscar M Vidal²

¹Department of Industrial Engineering, Universidad del Norte, Barranquilla 081007, Colombia.

International journal of molecular sciences

|November 27, 2024

概括

使者RNA (mRNA) 失调与阿尔茨海默病 (AD) 有关. 这项研究确定了特定的外体mRNA配置文件,可以准确预测AD诊断和发病年龄,为早期检测提供了潜力.

科学领域:

神经科学是一个神经科学.
遗传学遗传学是一个
生物标志物发现发现

背景情况:

阿尔茨海默病 (AD) 是一种进展性神经退行性疾病.
新出现的证据表明,信使RNA (mRNA) 失调是AD病理的一个因素.
外体mRNA为诊断生物标志物提供了一个潜在的来源.

研究的目的:

在AD患者中调查外体mRNA表达特征.
为了确定mRNA生物标志物用于AD诊断,并预测AD发病年龄 (ADAOO).
评估已识别的mRNA签名的诊断和预测准确性.

主要方法:

对15名阿尔茨海默病患者和15名哥伦比亚健康对照者的外体mRNA表达的分析.
生物信息学和机器学习 (ML) 技术的应用.
识别差异表达的mRNA和评估它们的预测能力.

主要成果:

在AD患者中,CADM1和TNFRSF19显著上调.
一组mRNAs (GABRB3,GGTLC1,CADM1,FOXJ3,ACY1) 在AD诊断中取得了90%以上的准确性.
特定的mRNAs (LIMK2,RNASE6,HNRNPU,PPP5D1,STN1,PPP2R1A) 显示了ADAOO的预测价值,其中RNASE6和PPP5D1在未见数据中显示出高准确性.

结论:

外体mRNA表达特征可以作为AD诊断的有效生物标志物.
识别的mRNA签名显示了预测AD发病年龄的潜力.
这些发现表明,早期AD检测和监测的最小侵入性,成本效益高的工具.

关键词:

阿尔茨海默氏症是阿尔茨海默氏症的一种疾病.外基因组是外基因组的组成部分.它们是mRNARNA.机器学习是机器学习.个性化医疗是个性化的医疗.

更多相关视频

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Author Spotlight: Exploring Sex-Specific Glial Signatures and Therapeutic Leads for Alzheimer's Disease

Published on: May 20, 2024

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

相关概念视频

Overview of Exosomes

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...

Alzheimer's Disease: Overview

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...

Nuclear Export of mRNA

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...